The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development.


Journal

Trends in cell biology
ISSN: 1879-3088
Titre abrégé: Trends Cell Biol
Pays: England
ID NLM: 9200566

Informations de publication

Date de publication:
10 2022
Historique:
received: 10 01 2022
revised: 27 03 2022
accepted: 30 03 2022
pubmed: 28 4 2022
medline: 14 9 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

More than 800 million people suffer from kidney disease. Genetic studies and follow-up animal models and cell biological experiments indicate the key role of proximal tubule metabolism. Kidneys have one of the highest mitochondrial densities. Mitochondrial biogenesis, mitochondrial fusion and fission, and mitochondrial recycling, such as mitophagy are critical for proper mitochondrial function. Mitochondrial dysfunction can lead to an energetic crisis, orchestrate different types of cell death (apoptosis, necroptosis, pyroptosis, and ferroptosis), and influence cellular calcium levels and redox status. Collectively, mitochondrial defects in renal tubules contribute to epithelial atrophy, inflammation, or cell death, orchestrating kidney disease development.

Identifiants

pubmed: 35473814
pii: S0962-8924(22)00084-8
doi: 10.1016/j.tcb.2022.03.012
pmc: PMC9464682
mid: NIHMS1817575
pii:
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

841-853

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK076077
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK087635
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK132630
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Cell Death Dis. 2021 Sep 13;12(9):847
pubmed: 34518519
J Am Soc Nephrol. 2021 Feb;32(2):342-356
pubmed: 33478973
Nat Rev Microbiol. 2018 Jul;16(7):423-439
pubmed: 29769653
Oxid Med Cell Longev. 2019 Jun 02;2019:2346580
pubmed: 31281569
Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4910-E4919
pubmed: 29735694
Nature. 2010 Mar 4;464(7285):121-5
pubmed: 20203611
Antioxid Redox Signal. 2014 Apr 1;20(10):1646-54
pubmed: 23886445
J Am Soc Nephrol. 2013 Oct;24(10):1545-57
pubmed: 23833261
J Am Soc Nephrol. 2019 Dec;30(12):2384-2398
pubmed: 31575700
Nature. 2018 Aug;560(7717):198-203
pubmed: 30046112
PLoS Pathog. 2018 Jul 20;14(7):e1007172
pubmed: 30028868
Sci Rep. 2021 Jul 30;11(1):15510
pubmed: 34330933
Redox Biol. 2017 Apr;11:297-311
pubmed: 28033563
Curr Opin Cell Biol. 2009 Dec;21(6):894-9
pubmed: 19781926
Kidney Int. 2013 Jul;84(1):138-48
pubmed: 23466994
Free Radic Biol Med. 2020 May 20;152:632-649
pubmed: 31825802
J Clin Invest. 2021 Oct 15;131(20):
pubmed: 34651582
Lab Invest. 2018 Jan;98(1):63-78
pubmed: 29106395
Science. 2018 Feb 23;359(6378):
pubmed: 29472455
J Am Soc Nephrol. 2011 Mar;22(3):431-6
pubmed: 21355058
Acta Pharmacol Sin. 2019 Jun;40(6):790-800
pubmed: 30382182
Kidney Int. 2011 Apr;79(8):871-82
pubmed: 21270762
Nature. 2016 Mar 24;531(7595):528-32
pubmed: 26982719
Kidney Int. 2019 Nov;96(5):1105-1120
pubmed: 31405732
Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F396-F407
pubmed: 30539655
Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1119-F1128
pubmed: 29846105
J Am Soc Nephrol. 2008 Dec;19(12):2331-41
pubmed: 18815244
Redox Biol. 2021 Jan;38:101767
pubmed: 33137712
J Mol Med (Berl). 2020 Apr;98(4):527-540
pubmed: 32036390
Nat Med. 2018 Sep;24(9):1351-1359
pubmed: 30127395
J Am Soc Nephrol. 2014 Dec;25(12):2689-701
pubmed: 24925726
Kidney Int. 2013 Apr;83(4):568-81
pubmed: 23325082
J Am Soc Nephrol. 2018 Apr;29(4):1165-1181
pubmed: 29439156
Nat Commun. 2021 Feb 11;12(1):963
pubmed: 33574248
Nature. 2021 Aug;596(7873):E13
pubmed: 34341547
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):
pubmed: 33579817
Nat Med. 2015 Jan;21(1):37-46
pubmed: 25419705
J Biol Chem. 2008 Apr 18;283(16):10892-903
pubmed: 18281291
J Clin Invest. 2015 Feb;125(2):715-26
pubmed: 25607838
Immunity. 2021 Nov 9;54(11):2632-2649.e6
pubmed: 34715018
Cell Death Dis. 2021 Apr 8;12(4):382
pubmed: 33833214
Nat Commun. 2017 Feb 08;8:14329
pubmed: 28176780
Antioxid Redox Signal. 2015 May 1;22(13):1111-29
pubmed: 25330206
Biochem Biophys Res Commun. 2018 Apr 15;498(4):918-924
pubmed: 29545177
Cell. 2017 Jan 12;168(1-2):224-238.e10
pubmed: 28017329
Cell. 2016 Nov 3;167(4):985-1000.e21
pubmed: 27881304
Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F122-F131
pubmed: 28903946
J Am Soc Nephrol. 2017 Aug;28(8):2337-2352
pubmed: 28246130
J Pharmacol Exp Ther. 2019 Apr;369(1):173-180
pubmed: 30709866
Am J Nephrol. 2017;46(2):131-138
pubmed: 28723681
J Pharmacol Exp Ther. 2014 Aug;350(2):257-64
pubmed: 24849926
Front Immunol. 2019 May 29;10:1223
pubmed: 31191559
Int J Nephrol Renovasc Dis. 2014 Jan 31;7:57-67
pubmed: 24516335
Diabetes. 2012 Mar;61(3):728-38
pubmed: 22315314
Int J Mol Sci. 2020 Apr 22;21(8):
pubmed: 32331329
Nat Cell Biol. 2014 Dec;16(12):1180-91
pubmed: 25402683
J Am Soc Nephrol. 2015 May;26(5):1092-102
pubmed: 25201884
Trends Immunol. 2019 Dec;40(12):1120-1133
pubmed: 31744765
Cell Chem Biol. 2020 Apr 16;27(4):448-462
pubmed: 32302582
J Clin Invest. 2009 May;119(5):1275-85
pubmed: 19349686
Mitochondrion. 2015 Nov;25:67-75
pubmed: 26437364
EBioMedicine. 2017 Dec;26:68-77
pubmed: 29128444
Kidney Int. 2012 Apr;81(8):751-61
pubmed: 22237751
J Am Soc Nephrol. 2018 Jul;29(7):1900-1916
pubmed: 29925521
Cell Rep. 2019 Oct 29;29(5):1261-1273.e6
pubmed: 31665638
Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1239-50
pubmed: 22896037
J Cell Biol. 2016 Feb 15;212(4):379-87
pubmed: 26858267
J Am Soc Nephrol. 2013 Mar;24(4):537-41
pubmed: 23334390
J Am Soc Nephrol. 2014 Jun;25(6):1237-54
pubmed: 24511132
Sci Adv. 2020 Oct 9;6(41):
pubmed: 33036968
Cell Death Dis. 2018 Aug 29;9(9):878
pubmed: 30158627
J Am Soc Nephrol. 2018 Apr;29(4):1223-1237
pubmed: 29440279
J Immunol. 2018 Aug 1;201(3):1073-1085
pubmed: 29898963
Commun Biol. 2021 Aug 26;4(1):1013
pubmed: 34446827
J Am Soc Nephrol. 2017 Jan;28(1):218-229
pubmed: 27352622
Am J Health Syst Pharm. 2013 Jul 15;70(14):1219-25
pubmed: 23820458
Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F382-F395
pubmed: 30207166
J Am Soc Nephrol. 2014 Jun;25(6):1157-62
pubmed: 24511124
J Immunol. 2021 Dec 1;207(11):2799-2812
pubmed: 34740957
Cell Death Differ. 2016 Sep 1;23(9):1565-76
pubmed: 27177019
Nat Rev Nephrol. 2017 Oct;13(10):629-646
pubmed: 28804120
Nat Commun. 2021 Aug 23;12(1):5078
pubmed: 34426578
Nat Commun. 2020 Feb 20;11(1):970
pubmed: 32080200
J Endocrinol. 2019 Jan 1;:
pubmed: 30620716
Sci Adv. 2021 Nov 05;7(45):eabi8051
pubmed: 34739325
J Am Soc Nephrol. 2010 Aug;21(8):1254-62
pubmed: 20651166
Cell Metab. 2020 Oct 6;32(4):676-688.e4
pubmed: 32791100
Redox Biol. 2020 Sep;36:101671
pubmed: 32829253
J Clin Invest. 2021 May 17;131(10):
pubmed: 33998598
Cell Metab. 2019 Oct 1;30(4):784-799.e5
pubmed: 31474566
Cell Death Dis. 2018 Sep 24;9(10):983
pubmed: 30250284
J Cell Mol Med. 2019 Jun;23(6):3995-4004
pubmed: 30993884
Kidney Int. 2013 Aug;84(2):285-96
pubmed: 23515048
J Am Soc Nephrol. 2016 Aug;27(8):2270-5
pubmed: 26832955
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F926-F937
pubmed: 28424210
J Am Soc Nephrol. 2018 Jan;29(1):194-206
pubmed: 29084809
Clin Sci (Lond). 2019 Jul 25;133(14):1609-1627
pubmed: 31315969
Sci Rep. 2016 Feb 05;6:20425
pubmed: 26846717
Aging Cell. 2020 Jun;19(6):e13154
pubmed: 32400101
J Clin Invest. 2019 Nov 1;129(11):5033-5049
pubmed: 31437128
Cell Death Dis. 2018 Nov 1;9(11):1113
pubmed: 30385753
Cell Death Dis. 2020 Aug 14;11(8):629
pubmed: 32796819
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33465052
J Am Soc Nephrol. 2017 Nov;28(11):3312-3322
pubmed: 28751525
FASEB J. 2020 Aug;34(8):10286-10298
pubmed: 32542792
Biomed Pharmacother. 2019 Jul;115:108914
pubmed: 31071510
Nature. 2010 Mar 4;464(7285):104-7
pubmed: 20203610
Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F238-F247
pubmed: 31760767
Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F260-F268
pubmed: 29046298
J Clin Invest. 1999 Sep;104(5):541-9
pubmed: 10487768
Elife. 2021 May 04;10:
pubmed: 33942716

Auteurs

Tomohito Doke (T)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA; Department of Genetics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: tomohito.doke@pennmedicine.upenn.edu.

Katalin Susztak (K)

Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA; Department of Genetics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: ksusztak@pennmedicine.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH